Neonatal Screening

Newborn Screening is a program that identifies babies at risk of having rare, but serious medical conditions that can affect normal development. Baby Shield Newborn Screening combines biochemical testing of 100+ metabolic & genetic conditions with confirmatory genetic testing for screen-positive results.It aims to achieve early identification of conditions. Thus, resulting in early intervention that can lead to the elimination or reduction of mortality, morbidity and disability in affected newborns.

 

    Related Conference of Neonatal Screening

    July 27-28, 2026

    3rd World Pediatric Conference

    London, UK
    August 18-19, 2026

    8th World Pediatric Infectious Disease Congress

    Paris, France
    September 07-08, 2026

    24rd World Congress on Clinical Pediatrics

    Toronto, Canada
    September 14-15, 2026

    26th Annual Congress on Pediatrics & Neonatology

    Rome, Italy
    October 05-06, 2026

    39th World Pediatrics Conference

    Madrid, Spain
    November 19-20, 2026

    37th European Pediatrics Conference

    Dubai, UAE
    December 03-04, 2026

    11th Annual Pediatric Congress

    Madrid, Spain
    December 29-30, 2026

    35th World Congress on Clinical Pediatrics

    Edinburgh, Scotland
    January 28-29, 2027

    8th Annual Congress on Pediatric Cardiology

    Vancouver, Canada
    February 11-12, 2027

    24th World Congress on Pediatric Oncology and Nursing

    Toronto, Canada
    February 11-12, 2027

    7th Global Summit on Pediatric Nursing

    Toronto, Canada
    February 18-19, 2027

    35th International Conference on Pediatrics and Neonatology

    Barcelona, Spain
    March 25-26, 2027

    6th World Congress on Pediatric Cardiology

    Amsterdam, Netherlands
    May 19-20, 2027

    39th European Pediatrics Congress

    London, UK

    Neonatal Screening Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in